CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
9 research outputs found
Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data
Author
AI Korbut
EJM van Bommel
+7Â more
I Tomita
K Hasegawa
M Packer
P Cassis
R Santer
V Perkovic
V Vallon
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes
Author
Bakker SJ
Danser AHJ
+12Â more
Ferrannini E
Geurts Frank
Hoorn Ewout
Joles JA
Kramer MHH
Muskiet MHA
Nieuwdorp M
Post Adrian
Touw DJ
van Berkel M
van Bommel EJM
van Raalte DH
Publication venue
'Portland Press Ltd.'
Publication date
01/01/2020
Field of study
No full text
EUR Research Repository
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Author
Bozovic A
Danser AHJ
+15Â more
Emanuel AL
Geurts Frank
Hoorn Ewout
Joles JA
Kramer MHH
Larsen EL
Muskiet MHA
Nieuwdorp M
Poulsen HE
Smits MM
Tonneijck L
Touw DJ
van Baar MJB
van Bommel EJM
van Raalte DH
Publication venue
'Elsevier BV'
Publication date
01/01/2020
Field of study
No full text
EUR Research Repository
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Author
A Asmar
A Denic
+61Â more
AT Layton
BJ von Scholten
BM Brenner
C Rm
C Wang
C-C Hung
DJ Drucker
DZI Cherney
E Espinel
EJ Lewis
EJ van Bommel
EJM van Bommel
FB Hickey
HC Gerstein
J Skov
J Titze
J-P Gutzwiller
JF Moorhead
JFE Mann
JJ Meier
JL Bahnson
K Li
KA Spit
KR Tuttle
L Tonneijck
L Tonneijck
L Tonneijck
L Tonneijck
LG Fine
LR Carraro-Lacroix
LS Bisgaard
M Husain
M Murea
MA Bethel
MA Nauck
MA Pfeffer
MC Bunck
MC Foster
MC Thomas
MHA Muskiet
MHA Muskiet
MHA Muskiet
MHA Muskiet
MHA Muskiet
MJ Davies
ML Marcovecchio
MV Karg
N Tsuboi
NH Cho
O Mosenzon
P Bjornstad
P Bjornstad
P Strazzullo
RT Gansevoort
SE Inzucchi
SL Kristensen
TA Zelniker
V Perkovic
V Perkovic
WV Tamborlane
Y Lytvyn
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Author
Abdul-Ghani MA
Baron-Franco B
+54Â more
Beck-da-Silva L
Boussageon R
Boussageon R
Braunschweig F
Cefalu WT
Clark AL
Cope LC
Cosentino F
Courtenay M.
Damman K
Dauriz M
Fitchett D
Fonarow GC.
Heerspink HJL
Hemmingsen B
Hormann SM
Huang H
Kimura G.
Kooy A
Kristensen SL
Kristensen SL
Lago RM
Lamanna C
Marso SP
Maruthur NM
McMurray JJV
Mentz RJ
Mogensen UM
Mordi NA
Neal B
Pittman JR
Ponikowski P
Rahelic´ D
Ribola FA
Salem CB
Scirica BM
Seferovic´ PM
Shimbo D
Suskin N
Swedberg K
Taylor CJ
Thompson DR
Turnbull FM
Vaduganathan M
Van Baar MJB
Van Bommel EJM
Vardeny O
Verma S
Wang Y
Wise J.
Wiviott SD
Yudkin JS
Zelniker TA
Zhang XL
Publication venue
'Mark Allen Group'
Publication date
Field of study
No full text
Crossref
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Author
Abdul-Ghani MA
Baron-Franco B
+57Â more
Beck-da-Silva L
Boussageon R
Boussageon R
Braunschweig F
Cefalu WT
Clark AL
Cope LC
Courtenay M
Damman K
Dauriz M
Fitchett D
Fonarow GC
Heerspink HJL
Hemmingsen B
Hormann SM
Huang H
Kimura G
Kooy A
Kristensen SL
Kristensen SL
Lago RM
Lamanna C
Marso SP
Maruthur NM
McMurray JJV
Mentz RJ
Mogensen UM
Mordi NA
National Clinical Guideline Centre
National Insitute of Clinical and Health Excellence
National Insitute of Clinical and Health Excellence
Neal B
Pittman JR
Ponikowski P
Rahelić D
Ribola FA
Salem CB
Scirica BM
Seferović PM
Shimbo D
Stewart S
Suskin N
Swedberg K
Taylor CJ
Thompson DR
Turnbull FM
Vaduganathan M
Van Baar MJB
Van Bommel EJM
Vardeny O
Verma S
Wang Y
Wise J
Wiviott SD
Yudkin JS
Zelniker TA
Zhang XL
Publication venue
'Mark Allen Group'
Publication date
Field of study
No full text
Crossref
Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease
Author
A Garcia-Ropero
A Kashiwagi
+84Â more
A Sarashina
AH Barnett
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
AJ Scheen
André J. Scheen
AS Allegretti
B Neal
B Zinman
BL Neuen
BL Neuen
C Deerochanawong
C Lo
C Pollock
C Wanner
C Wanner
CCJ Dekkers
CCJ Dekkers
CCJ Dekkers
CG Santos-Gallego
CP Cannon
D Devineni
DE Kohan
DZ Cherney
E Ferrannini
E Flores
EJM van Bommel
F Cosentino
G Grunberger
H Rajasekeran
H Yamout
HJL Heerspink
HJL Heerspink
J Li
J Nespoux
JA Davidson
JB Buse
JF Yale
JF Yale
JJV McMurray
K Kidokoro
KR Tuttle
KW Mahaffey
LL Lim
M Haneda
M Packer
M Saito
MJ Davies
MS Kelly
N Inagaki
National Kidney Foundation
O Mosenzon
P Delanaye
P Fioretto
P Sarafidis
R Roussel
RA DeFronzo
RZ Alicic
S Ikeda
S Kasichayanula
S Macha
S Verma
SD Anker
SD Wiviott
SE Inzucchi
T Kadowaki
T Toyama
TA Zelniker
V Perkovic
V Perkovic
V Perkovic
V Sahasrabudhe
WG Herrington
X Cai
XL Cai
Y Fujita
Y Samukawa
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives
Author
A Kashiwagi
A Kashiwagi
+98Â more
A Kashiwagi
A Kramer
A Piperidou
A Solini
Alexia Piperidou
American Diabetes Association
AN Lasaridis
AS Go
B Neal
B Neal
B Williams
BL Neuen
BM Brenner
BM Brenner
C Loutradis
C Wanner
Charalampos Loutradis
D Cherney
DE Kohan
DE Kohan
DZ Cherney
DZI Cherney
DZI Cherney
E Ferrannini
EC Chao
EJ Lewis
EJ Lewis
EJM van Bommel
EM Wright
EM Wright
EM Wright
EM Wright
F Artunc
G Danaei
G Ruiz-Hurtado
G Vlotides
GL Bakris
GL Bakris
HH Parving
HJ Heerspink
HJ Heerspink
HJ Heerspink
HJ Heerspink
HJ Lambers Heerspink
HJL Heerspink
J Jordan
J O’Neill
JB Buse
JF Yale
JL Górriz
JT Wright Jr.
K Ogurtsova
K Tamura
KDIGO
KDIGO.
L Norton
LF Fried
LM Ruilope
M Haneda
M Ridderstrale
M Tonelli
MA Abdul-Ghani
MA Nauck
MA Nauck
ME Alexandrou
MH Muskiet
MJ Soler
N Drey
N Khosla
N Terami
NC Edwards
O Mosenzon
P Dandona
P Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
PA Sarafidis
Pantelis Sarafidis
PK Whelton
R Chilton
R Saran
RA DeFronzo
SD Wiviott
TD Filippatos
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)
V Perkovic
V Perkovic
VS Stel
WG Couser
WT Cefalu
Y Chino
YK Chang
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application
Author
A De La Vieja
A Denic
+214Â more
A Di Franco
A Diez-Sampedro
A Diez-Sampedro
A Ghosal
A Gonzalez-Vicente
A Hazama
A Lopez-Barradas
A Novikov
A Oku
A Onishi
A Penmatsa
A Schork
A Watanabe
A Yamashita
A Yasui
AA Voss
AB Byrne
AD Baron
AD Vadlapudi
AI Adler
AJ Scheen
AW Moran
B Mackenzie
B Thorens
B Webb
B Webb
BL Neuen
C Bonner
C Fernandez-Rozadilla
C Ghezzi
C Ghezzi
C Perez
C Scafoglio
C Ung
C UniProt
CG Salter
CJ Bailey
CS Hummel
CSP Lam
D Deng
D Magen
D Polidori
DD Loo
DD Loo
DM Kendall
DR Koes
DR Powell
DW Barfuss
DZ Cherney
E Ferrannini
E Gopal
E Kurosaki
E Ottosson-Laakso
E Turk
EJM van Bommel
EM Wright
EM Wright
EM Wright
F Gatto
F Grahammer
F Prattichizzo
F Sievers
F Sievers
F Stumpel
FD de Carvalho
G Burnstock
G Dai
G You
G You
Gergely Gyimesi
GL Kellett
GL Kellett
GM Morris
GT Berry
H Gunshin
H Iwamoto
H Kobori
H Rahmoune
H Reyes-Pardo
H Tsukaguchi
H Umino
HM Kwon
I Letunic
I Vrhovac
J Calado
J Klisic
J Nespoux
J Schnermann
J Wilding
J Zhang
JA Coleman
JB Peng
JC Skou
Jonai Pujol-Giménez
JP Nicola
JR Ehrenkranz
JR Thiagarajah
JSJ Vinke
K Arakawa
K Kidokoro
K Mori
KJ Simmons
L Bianchi
L Parent
L Rossetti
L Tonneijck
L Yu
L Yu
LA Gallo
LJ Tsai
LP van den Heuvel
M Cannizzaro
M Li
M Mannstadt
M Mueckler
M Packer
M Paroder-Belenitsky
M Pohl
M Pontoglio
M Quick
M Quick
M Sala-Rabanal
M Sala-Rabanal
M Sala-Rabanal
M Sotak
M Thangaraju
MA Abdul-Ghani
MA Hediger
MA Hediger
MA Hediger
MA Hediger
MA Hediger
Matthias A. Hediger
MF Romero
MH Saier Jr
MJ Coady
MJ Coady
MJ Jurczak
MP Vawter
MS Salker
MT Guillam
N Harada
N Nakamura
N Schafer
NM Tabatabai
O Jardetzky
O Vardeny
OJ Enogieru
P Bisignano
P Kandasamy
P Komlosi
P Roll
P Song
PB Hansen
PC Lee
PV Roder
R Grempler
R Ohgaki
R Quiroga
RG Wells
RG Wells
RK Crane
RK Kothinti
RZ Sabirov
RZ Sabirov
S El-Gebali
S Eskandari
S Faham
S Guindon
S Miyauchi
S Ravera
S Sabui
S Sabui
S Sivaprakasam
S Srivastava
S Tazawa
SI Taylor
SJ Blakemore
SJ Loomis
SK Bhavsar
SM Ferguson
SM Gisler
SP Shirazi-Beechey
SR Srinivas
T Baader-Pagler
T Fukuzawa
T Haga
T Okuda
T Rieg
T Yamanouchi
T Zeuthen
TA Zelniker
V Ganapathy
V Gorboulev
V Kepe
V Lefort
V Vallon
V Vallon
VK Nguyen
VX Farias
WS Lee
WT Cefalu
WY Wahlgren
X Lin
X Wang
XZ Chen
Y Kanai
Y Kanai
Y Kobayashi
Y Zhang
YD Bhutia
YJ Fei
Yoshikatsu Kanai
Z Dai
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref